Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020123970> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2020123970 endingPage "69" @default.
- W2020123970 startingPage "69" @default.
- W2020123970 abstract "Objectives: Ixabepilone for endometrial/ovarian cancer has been evaluated as a single agent in phase II studies (Gynecologic Oncology Group [GOG] 129P, GOG 126M) and is currently under investigation in conjunction with carboplatin/bevacizumab (GOG 86P). This study describes the institutional experience of weekly ixabepilone±biweekly bevacizumab in treatment of platinum/taxane-resistant endometrial and ovarian cancers." @default.
- W2020123970 created "2016-06-24" @default.
- W2020123970 creator A5002826928 @default.
- W2020123970 creator A5008166734 @default.
- W2020123970 creator A5010339370 @default.
- W2020123970 creator A5021257078 @default.
- W2020123970 creator A5026827320 @default.
- W2020123970 creator A5032849063 @default.
- W2020123970 creator A5035381883 @default.
- W2020123970 creator A5052390359 @default.
- W2020123970 creator A5066823675 @default.
- W2020123970 date "2014-06-01" @default.
- W2020123970 modified "2023-09-28" @default.
- W2020123970 title "Weekly ixabepilone with or without concurrent bevacizumab in the treatment of platinum/taxane-resistant endometrial and ovarian cancers: An institutional experience" @default.
- W2020123970 doi "https://doi.org/10.1016/j.ygyno.2014.03.187" @default.
- W2020123970 hasPublicationYear "2014" @default.
- W2020123970 type Work @default.
- W2020123970 sameAs 2020123970 @default.
- W2020123970 citedByCount "0" @default.
- W2020123970 crossrefType "journal-article" @default.
- W2020123970 hasAuthorship W2020123970A5002826928 @default.
- W2020123970 hasAuthorship W2020123970A5008166734 @default.
- W2020123970 hasAuthorship W2020123970A5010339370 @default.
- W2020123970 hasAuthorship W2020123970A5021257078 @default.
- W2020123970 hasAuthorship W2020123970A5026827320 @default.
- W2020123970 hasAuthorship W2020123970A5032849063 @default.
- W2020123970 hasAuthorship W2020123970A5035381883 @default.
- W2020123970 hasAuthorship W2020123970A5052390359 @default.
- W2020123970 hasAuthorship W2020123970A5066823675 @default.
- W2020123970 hasConcept C121608353 @default.
- W2020123970 hasConcept C126322002 @default.
- W2020123970 hasConcept C143998085 @default.
- W2020123970 hasConcept C2775930923 @default.
- W2020123970 hasConcept C2776694085 @default.
- W2020123970 hasConcept C2777511904 @default.
- W2020123970 hasConcept C2777802072 @default.
- W2020123970 hasConcept C2779194965 @default.
- W2020123970 hasConcept C29456083 @default.
- W2020123970 hasConcept C530470458 @default.
- W2020123970 hasConcept C71924100 @default.
- W2020123970 hasConceptScore W2020123970C121608353 @default.
- W2020123970 hasConceptScore W2020123970C126322002 @default.
- W2020123970 hasConceptScore W2020123970C143998085 @default.
- W2020123970 hasConceptScore W2020123970C2775930923 @default.
- W2020123970 hasConceptScore W2020123970C2776694085 @default.
- W2020123970 hasConceptScore W2020123970C2777511904 @default.
- W2020123970 hasConceptScore W2020123970C2777802072 @default.
- W2020123970 hasConceptScore W2020123970C2779194965 @default.
- W2020123970 hasConceptScore W2020123970C29456083 @default.
- W2020123970 hasConceptScore W2020123970C530470458 @default.
- W2020123970 hasConceptScore W2020123970C71924100 @default.
- W2020123970 hasLocation W20201239701 @default.
- W2020123970 hasOpenAccess W2020123970 @default.
- W2020123970 hasPrimaryLocation W20201239701 @default.
- W2020123970 hasVolume "133" @default.
- W2020123970 isParatext "false" @default.
- W2020123970 isRetracted "false" @default.
- W2020123970 magId "2020123970" @default.
- W2020123970 workType "article" @default.